Links Archive
APA RushNotes
May 17, 2010
May 10, 2010
May 3, 2010
April 26, 2010
April 19, 2010
April 5, 2010
March 29, 2010 - Health Reform Special Report
March 22, 2010
March 15, 2010
March 1, 2010
January 25, 2010
January 11, 2010
December 21, 2009
December 14, 2009
November 23, 2009
November 9, 2009
November 2, 2009
October 19, 2009
October 12, 2009
October 5, 2009
September 28, 2009
September 21, 2009
- added 11.20.09 -
Update - Red Flags Rule
Update: The Federal Trade Commission (FTC) has delayed the compliance deadline of the Red Flags Rule until June 1, 2010. The AMA will utilize this time to convince the FTC and Congress to republish the rule so that there is sufficient opportunity to formally comment and state the AMA's objections to physician inclusion in the program.
http://www.ama-assn.org/ama/no-index/physician-resources/red-flags-rule.shtml
- added 10.12.09 -
Governor Vetoes AB 244 (Beall) Mental Health Parity Bill
Click this link for news report
- added 10.6.09 -
'Minds On The Edge'
MINDS ON THE EDGE: Facing Mental Illness is a multi-platform media project that explores severe mental illness in America. The centerpiece of the project is a television program airing on PBS stations in October 2009.
- added 9.19.09 -
'Opinions of the Ethics Committee on the Principles of Medical Ethics'
The APA Ethics Committee has completed its revision of The Opinions of the Ethics Committee on the Principles of Medical Ethics, 2009 Edition. As we discussed during the annual Ethics Committee luncheon in May, the Ethics Committee has categorized the new opinions document by topics which should facilitate ease of use of the document. The Committee does appreciate the feedback received from many of you during the drafting period.
The new document has been posted on the APA website. You can view the .pdf document by clicking here. The APA is ‘going green’ so we encourage you to view the document online and direct other members and general public to do so as well. If you need a hard copy, please contact Allison Moraske in the APA Ethics Office - amoraske@psych.org.
Wade C. Myers, M.D.
Chair, APA Ethics Committee
SCPS Program Committee would like to thank all of our speakers, exhibitors, and attendees
for making this year's annual meeting a successful event!
Psychopharmacology Update 21
for making this year's annual meeting a successful event!
Psychopharmacology Update 21
-
Saturday, January 30, 2010
The Olympic Collection
11301 Olympic Blvd.
Los Angeles, CA 90064
310-575-4585
8:30 a.m - Registration, Continental Breakfast, Booth Exhibits
8:55 a.m. - Opening Remarks
9:00 a.m. - Generic Drugs: Good Values or Bad Bargains?
James W. Jefferson, M.D., Clinical Professor of Psychiatry, University of Wisconsin School of Medicine and Public Health and Distinguished Senior Scientist Madison Institute of Medicine.
The Federal Drug Price Competition and Patent Term Restoration Act of 1984 opened the floodgates to generic drugs by removing requirements for independently establishing efficacy and safety, and by basing approval on bioequivalence. The process required to establish bioequivalence will be discussed, as well as related relevant terms and concepts. The pros and cons of generic prescribing will be discussed and illustrated by examples involving antidepressants.
10:00 a.m. - Managing Depression During Pregnancy: Latest Consensus Findings and Guidelines
Vivien Burt, M.D., Ph.D., Professor Emeritus of Psychiatry, UCLA; Founder/Director, The Women’s Life Center, UCLA.
Between 14% and 23% of pregnant women will experience a depressive disorder while pregnant. In 2003, about 13% of women took an antidepressant at some point during pregnancy, double the rate since 1999. In order to provide full and comprehensive care that maximizes safety for mothers and their babies, it is thus relevant and important for clinicians to know and understand the information on the treatment of perinatal depression. The latest literature on fetal and neonatal outcomes associated with depression and antidepressant treatment during pregnancy will be reviewed. Research findings, guidelines and algorithms for preconception and antenatal management will be presented and discussed.
11:00 a.m. - Break
11:15 a.m. - An Evidence Based "How to Guide" for Antidepressant Augmentation Strategies
David L. Fogelson, M.D., Clinical Professor of Psychiatry, UCLA Department of Psychiatry and Biobehavioral Sciences.
When a patient does not respond to an adequate trial of an antidepressant, how do you decide what to use for augmentation? What do the most current treatment algorithms recommend? We will review combinations of antidepressants, buspirone, T3, lithium, lamotrigine, atypical antipsychotics, pindolol, psychostimulants, nutraceuticals, benzodiazepines, and psychotherapy as strategies for antidepressant augmentation.
12:15 p.m. - Lunch (lunch will not be provided.)
1:30 p.m. - Problematic Hypersexuality: Diagnosis and Treatment
John Sealy, M.D., Assistant Clinical Professor of Psychiatry UCLA School of Medicine.
Problematic hypersexuality, often referred to as sexual addiction, is an increasingly common behavior complaint across a broad age span. Although this disorder remains on the frontier of psychiatry, guidelines for diagnosis, comorbidities, consequences and treatment will be discussed to help clinicians make effective interventions. Problematic Hypersexuality, often referred to as sexual addiction, is an increasingly more common behavior complaint from patients, including adolescents. The consequences can be devastating for the patient and those who love him or her. Alhtough this disorder remains on the frontier of psychiatry, guidelines for diagnosis, comorbidities, consequences and treatment will be discussed to hep clinicians make effedtive interventions.
2:30 p.m. - Performance Enhancing Drugs: from High School to the Olympic Games
Don H. Catlin, M.D.,UCLA Professor of Molecular and Medical Pharmacology, Emeritus CEO, Anti- Doping Research.
Sport has been coping with drugs and sport for fifty years. The presentation will explain the type of drugs that are used, and comment on questions such as: How pervasive are they? Do they really enhance performance? Why do athletes continue to use them? How effective are the testing schemes? The presentation will also offer a brief overview of the use of performance enhancing drugs in school and the work place as well as reflection on the social and cultural implications of performance enhancing drugs in general.
The Southern California Psychiatric Society (SCPS) is accredited by the Institute of Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. SCPS takes responsibility for the content, quality and scientific integrity of this CME activity.
SCPS designates this educational activity for a maximum of 5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
Copyright 2010 SCPS